Considerations for monitoring and evaluating treatment effects in clinical trials.

[1]  David P. Harrington,et al.  Procedures for Serial Testing in Censored Survival Data , 1984 .

[2]  Anastasios A. Tsiatis,et al.  Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , 1982 .

[3]  Eric V. Slud,et al.  Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic , 1982 .

[4]  D. Harrington.  A class of rank test procedures for censored survival data , 1982 .

[5]  Mitchell H. Gail,et al.  Simulation Studies on Increments of the Two-Sample Logrank Score Test for Survival Time Data, with Application to Group Sequential Boundaries , 1982 .

[6]  D. DeMets,et al.  Fundamentals of Clinical Trials , 1982 .

[7]  James H. Ware,et al.  On distribution-free tests for equality of survival distributions , 1977 .

[8]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[9]  T. Chalmers.  Randomization of the first patient. , 1975, The Medical clinics of North America.

[10]  K McPherson,et al.  Statistics: the problem of examining accumulating data more than once. , 1974, The New England journal of medicine.

[11]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[12]  R. Peto,et al.  Asymptotically efficient rank invariant test procedure (with discussion). , 1972 .

[13]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data , 1969 .

[14]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[15]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .